Eiko LifeSciences Ltd. engages in acquiring, selling and investing in shares, bonds, and stocks. The company is headquartered in Thane, Maharashtra. The company went IPO on 2016-12-13. The firm is engaged in the manufacturing of specialty chemicals and intermediates for pharmaceuticals, performance chemicals for industrial applications, and material sciences. The Company’s specialty chemicals product offerings comprise of organic as well as inorganic chemicals. Its products are used in the pharmaceuticals, agrochemicals, aroma chemicals and electronic chemicals sector. The firm's factory is located in Badlapur, Thane District.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.
15 fields couldn't be derived. The company was scraped before the cash-flow and balance-sheet rows were captured. Re-running an analysis will refresh these.